This brand name is authorized in United Kingdom, United States
The drug ACTHREL contains one active pharmaceutical ingredient (API):
UNII 56X54T817Q - CORTICORELIN OVINE TRIFLUTATE
Corticorelin results in a rapid and sustained increase of plasma ACTH levels and a near parallel increase of plasma cortisol. In addition corticorelin causes a concomitant and prolonged release of the related proopiomelanocortin peptides β- and γ-lipotropins (β- and γ-LPH) and β-endorphin (β-END).
Below package inserts are available for further reading:
|ACTHREL Powder for solution for injection
|FDA, National Drug Code (US)
|MPI, US: SPL/Old
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
|H Systemic hormonal preparations, excl. Sex hormones and insulins → H01 Pituitary and hypothalamic hormones and analogues → H01A Anterior pituitary lobe hormones and analogues → H01AA ACTH
This drug has been assigned below unique identifiers within the countries it is being marketed:
|Medicines & Healthcare Products Regulatory Agency
|FDA, National Drug Code
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.